A new monitoring system for detecting breathing issues in premature babies
Continuous Respiratory Monitoring Platform for Classifying Apnea of Prematurity
This study is working on a new way to keep an eye on premature babies to better spot and understand their breathing pauses, helping doctors provide safer and better care for these little ones.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Makani Science, INC. NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11041360 on NIH RePORTER |
What this research studies
This research focuses on developing a continuous monitoring platform specifically designed to classify apnea of prematurity (AOP) in newborns. The project aims to create a multimodal monitoring system that utilizes advanced sensors and machine learning algorithms to accurately identify different types of apnea in premature infants. By improving the detection and classification of AOP, healthcare providers can enhance patient care and safety. The research will be conducted in collaboration with the Children’s Hospital of Orange County, ensuring a clinical perspective in the development process.
Who could benefit from this research
Good fit: Ideal candidates for this research are premature newborns, particularly those under 4 weeks old, who are at risk for apnea of prematurity.
Not a fit: Patients who are not premature or those over 4 weeks old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and treatment of apnea in premature infants, potentially reducing complications and enhancing long-term health outcomes.
How similar studies have performed: Previous research has shown promise in using advanced monitoring technologies for similar conditions, indicating potential for success in this novel approach.
Where this research is happening
Irvine, United States
- Makani Science, INC. — Irvine, United States (Active)
Researchers
- Principal investigator: Chu, Michael — Makani Science, INC.
- Study coordinator: Chu, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.